United Kingdom

Daiichi Sankyo Co Ltd (4568.T)

4568.T on Tokyo Stock Exchange

28 Apr 2016
Change (% chg)

¥-58 (-2.18%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low


Chart for 4568.T


DAIICHI SANKYO COMPANY, LIMITED is a Japan-based holding company mainly engaged in the manufacture and sale of pharmaceuticals. The Company is involved in the research, development, manufacture and sale of pharmaceuticals, as well as the provision of intermediates and basic materials for pharmaceutical producing in Japan, the... (more)


Beta: 0.89
Market Cap(Mil.): ¥1,844,139.00
Shares Outstanding(Mil.): 709.01
Dividend: 30.00
Yield (%): 2.31


  4568.T Industry Sector
P/E (TTM): 32.06 33.80 45.25
EPS (TTM): 81.14 -- --
ROI: 3.42 13.05 12.52
ROE: 4.60 13.77 13.42
Search Stocks

BRIEF-Portola signs agreement with Daiichi Sankyo to develop andexanet alfa as an antidote for edoxaban

* Portola pharmaceuticals enters into clinical collaboration agreement with daiichi sankyo to develop andexanet alfa with edoxaban in japan

04 Apr 2016

BRIEF-BioInvent says receives EUR 2 mln milestone payment from Daiichi Sankyo

* Says receives EUR 2 million milestone payment from Daiichi Sankyo for licensed n-CoDeR antibody progressing into Phase I clinical trial in the EU For the original story click here: http://mb.cision.com/Main/583/9926129/482926.pdf Further company coverage: (Stockholm Newsroom)

29 Feb 2016

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider : GlobalData
Provider : MarketLine
Provider : Reuters Investment Profile

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks